Cardiovascular disease risk of abdominal obesity vs. metabolic abnormalities

Obesity

Volumn 19, Issue 4, 2011, Pages 853-860

  Wildman, Rachel P ^a   McGinn, Aileen P ^a   Lin, Juan ^a   Wang, Dan ^a   Muntner, Paul ^b   Cohen, Hillel W ^a   Reynolds, Kristi ^c   Fonseca, Vivian ^d   Sowers, Maryfran R ^e  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c KAISER PERMANENTE   (United States)

^d TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^e UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL OBESITY; ADOLESCENT; ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHILD; CIGARETTE SMOKING; CONTROLLED STUDY; DEMOGRAPHY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PRESCHOOL CHILD; PROGNOSIS; RISK ASSESSMENT; SCHOOL CHILD; STROKE; WAIST CIRCUMFERENCE;

EID: 79953174580     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2010.168     Document Type: Article

References (28)

1. Wildman RP, Muntner P, Reynolds K et al. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Arch Intern Med 2008;168:1617-1624.
2. Katzmarzyk PT, Janssen I, Ross R, Church TS, Blair SN. The importance of waist circumference in the definition of metabolic syndrome: prospective analyses of mortality in men. Diabetes Care 2006;29 404-409 (Pubitemid 44106526)
3. Song Y Manson JE, Meigs JB et al. Comparison of usefulness of body mass index versus metabolic risk factors in predicting 10-year risk of cardiovascular events in women. Am J Cardiol 2007;100:1654-1658. (Pubitemid 350130235)
4. Shin MJ, Hyun YJ, Kim OY et al. Weight loss effect on inflammation and LDL oxidation in metabolically healthy but obese (MHO) individuals: low inflammation and LDL oxidation in MHO women. Int J Obes (Lond) 2006;30:1529-1534 (Pubitemid 44470202)
5. Karelis AD, Messier V, Brochu M, Rabasa-Lhoret R. Metabolically healthy but obese women: effect of an energy-restricted diet. Diabetologia 2008;51:1752-1754
6. Kip KE, Marroquin OC, Kelley DE et al. Clinical importance of obesity versus the metabolic syndrome in cardiovascular risk in women: a report from the Women's Ischemia Syndrome Evaluation (WISE) study Circulation 2004;109:706-713. (Pubitemid 38222888)
7. Schulte H, Cullen P, Assmann G. Obesity mortality and cardiovascular disease in the Münster Heart Study (PROCAM). Atherosclerosis 1999;144:199-209. (Pubitemid 29259981)
8. Meigs JB, Wilson PW, Fox CS et al. Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab 2006;91:2906-2912 (Pubitemid 44271734)
9. Hu G, Tuomilehto J, Silventoinen K et al. Body mass index, waist circumference, and waist-hip ratio on the risk of total and type-specific stroke. Arch Intern Med 2007;167:1420-1427 (Pubitemid 47052442)
10. Rosengren A, Wilhelmsen L, Lappas G, Johansson S. Body mass index, coronary heart disease and stroke in Swedish women. A prospective 19-year follow-up in the BEDA study Eur J Cardiovasc Prev Rehabil 2003;10:443-450. (Pubitemid 39127677)
11. Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 1983;67: 968-977 (Pubitemid 13080473)
12. St-Pierre AC, Cantin B, Mauriège P et al. Insulin resistance syndrome, body mass index and the risk of ischemic heart disease. CMAJ 2005;172:1301-1305. (Pubitemid 40745071)
13. Flint AJ, Hu FB, Glynn RJ et al. Excess weight and the risk of incident coronary heart disease among men and women. Obesity (Silver Spring) 2010;18:377-383
14. Kannel WB, Feinleib M, McNamara PM, Garrison RJ, Castelli WP. An investigation of coronary heart disease in families. The Framingham off spring study Am J Epidemiol 1979;110:281-290. (Pubitemid 10204328)
15. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. Am J Epidemiol 1989;129:687-702.
16. Fried LP, Borhani NO, Enright P et al. The Cardiovascular Health Study: design and rationale. Ann Epidemiol 1991;1:263-276.
17. Ettinger WH, Wahl PW, Kuller LH et al. Lipoprotein lipids in older people. Results from the Cardiovascular Health Study The CHS Collaborative Research Group. Circulation 1992;86:858-869
18. Shahar E, Chambless LE, Rosamond WD et al.; Atherosclerosis Risk in Communities Study Plasma lipid profile and incident ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) study Stroke 2003;34 623-631 (Pubitemid 36307382)
19. Meigs JB, Cupples LA, Wilson PW. Parental transmission of type 2 diabetes: the Framingham Off Spring Study Diabetes 2000;49:2201-2207
20. Kannel WB, Vasan RS, Keyes MJ, Sullivan LM, Robins SJ. Usefulness of the triglyceride-high-density lipoprotein versus the cholesterol-high-density lipoprotein ratio for predicting insulin resistance and cardiometabolic risk (from the Framingham Off Spring Cohort). Am J Cardiol 2008;101:497-501 (Pubitemid 351199440)
21. Atherosclerosis Risk in Communities Limited Access Data. 2008. www. cscc.unc.edu/aric 16 Jun 2008. Ref Type: Internet Communication
22. Meigs JB, Nathan DM, Wilson PW, Cupples LA, Singer DE. Metabolic risk factors worsen continuously across the spectrum of nondiabetic glucose tolerance. The Framingham Off Spring Study Ann Intern Med 1998;128: 524-533 (Pubitemid 28177659)
23. Grundy SM, Cleeman JI, Daniels SR et al.; American Heart Association National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005;112 2735-2752 (Pubitemid 41532612)
24. Rosamond WD, Folsom AR, Chambless LE et al. Stroke incidence and survival among middle-aged adults: 9-year follow-up of the Atherosclerosis Risk in Communities (ARIC) cohort. Stroke 1999;30:736-743. (Pubitemid 29156360)
25. White AD, Folsom AR, Chambless LE et al. Community surveillance of coronary heart disease in the Atherosclerosis Risk in Communities (ARIC) Study: methods and initial two years' experience. J Clin Epidemiol 1996;49:223-233 (Pubitemid 26123934)
26. Ives DG, Fitzpatrick AL, Bild DE et al. Surveillance and ascertainment of cardiovascular events. The Cardiovascular Health Study Ann Epidemiol 1995;5:278-285.
27. Stokes J 3rd, Kannel WB, Wolf PA, Cupples LA, DAgostino RB. The relative importance of selected risk factors for various manifestations of cardiovascular disease among men and women from 35 to 64 years old: 30 years of follow-up in the Framingham Study Circulation 1987;75:V65-V73.
28. Oflaz H, Ozbey N, Mantar F et al. Determination of endothelial function and early atherosclerotic changes in healthy obese women. Diabetes Nutr Metab 2003;16:176-181 (Pubitemid 37406819)